SIOP PODC–adapted treatment guidelines for craniopharyngioma in low- and middle-income settings

Nisreen Amayiri; Ariane Spitaels; Mohamed Zaghloul; Anthony Figaji; Sergio Cavalheiro; Hermann L. Muller; Moawia Elhassan; Jeannette Parkes; Naureen Mushtaq; Mohamed El Beltagy; Yacoub A. Yousef; Natia Esiashvili; Michael Sullivan; Marcos Devanir da Costa; Patricia Dastoli; Fatima Mubarak; Ute Bartels; Omar Chamdine; Alan Davidson; Awni Musharbash; Patricia Alcasabas; Eric Bouffet; Simon Bailey

doi:10.1002/pbc.28493

SIOP PODC–adapted treatment guidelines for craniopharyngioma in low- and middle-income settings

Nisreen Amayiri, Ariane Spitaels, Mohamed Zaghloul, Anthony Figaji, Sergio Cavalheiro, Hermann L. Muller, Moawia Elhassan, Jeannette Parkes, Naureen Mushtaq, Mohamed El Beltagy, Yacoub A. Yousef, Natia Esiashvili, Michael Sullivan, Marcos Devanir da Costa, Patricia Dastoli, Fatima Mubarak, Ute Bartels, Omar Chamdine, Alan Davidson, Awni MusharbashPatricia Alcasabas, Eric Bouffet, Simon Bailey

Department of Oncology, Medical College, Pakistan

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Abstract

Pediatric craniopharyngioma is a rare tumor with excellent survival but significant long-term morbidities due to the loco-regional tumor growth or secondary to its treatment. Visual impairment, panhypopituitarism, hypothalamic damage, and behavioral changes are among the main challenges. This tumor should be managed under the care of a multidisciplinary team to determine the optimum treatment within the available resources. This is particularly important for low middle-income countries where resources are variable. This report provides risk-stratified management guidelines for children diagnosed with craniopharyngioma in a resource-limited setting.

Original language	English
Article number	e28493
Journal	Pediatric Blood and Cancer
Volume	70
Issue number	11
DOIs	https://doi.org/10.1002/pbc.28493
Publication status	Published - Nov 2023

Keywords

LMIC
SIOP PODC
adapted guidelines
craniopharyngioma

Access to Document

10.1002/pbc.28493

Cite this

Amayiri, N., Spitaels, A., Zaghloul, M., Figaji, A., Cavalheiro, S., Muller, H. L., Elhassan, M., Parkes, J., Mushtaq, N., Beltagy, M. E., Yousef, Y. A., Esiashvili, N., Sullivan, M., da Costa, M. D., Dastoli, P., Mubarak, F., Bartels, U., Chamdine, O., Davidson, A., ... Bailey, S. (2023). SIOP PODC–adapted treatment guidelines for craniopharyngioma in low- and middle-income settings. Pediatric Blood and Cancer, 70(11), Article e28493. https://doi.org/10.1002/pbc.28493

@article{4f0d87f182e54ce5bf472e7f16b294f7,

title = "SIOP PODC–adapted treatment guidelines for craniopharyngioma in low- and middle-income settings",

abstract = "Pediatric craniopharyngioma is a rare tumor with excellent survival but significant long-term morbidities due to the loco-regional tumor growth or secondary to its treatment. Visual impairment, panhypopituitarism, hypothalamic damage, and behavioral changes are among the main challenges. This tumor should be managed under the care of a multidisciplinary team to determine the optimum treatment within the available resources. This is particularly important for low middle-income countries where resources are variable. This report provides risk-stratified management guidelines for children diagnosed with craniopharyngioma in a resource-limited setting.",

keywords = "LMIC, SIOP PODC, adapted guidelines, craniopharyngioma",

author = "Nisreen Amayiri and Ariane Spitaels and Mohamed Zaghloul and Anthony Figaji and Sergio Cavalheiro and Muller, {Hermann L.} and Moawia Elhassan and Jeannette Parkes and Naureen Mushtaq and Beltagy, {Mohamed El} and Yousef, {Yacoub A.} and Natia Esiashvili and Michael Sullivan and {da Costa}, {Marcos Devanir} and Patricia Dastoli and Fatima Mubarak and Ute Bartels and Omar Chamdine and Alan Davidson and Awni Musharbash and Patricia Alcasabas and Eric Bouffet and Simon Bailey",

note = "Publisher Copyright: {\textcopyright} 2020 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.",

year = "2023",

month = nov,

doi = "10.1002/pbc.28493",

language = "English",

volume = "70",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "11",

}

Amayiri, N, Spitaels, A, Zaghloul, M, Figaji, A, Cavalheiro, S, Muller, HL, Elhassan, M, Parkes, J, Mushtaq, N, Beltagy, ME, Yousef, YA, Esiashvili, N, Sullivan, M, da Costa, MD, Dastoli, P, Mubarak, F, Bartels, U, Chamdine, O, Davidson, A, Musharbash, A, Alcasabas, P, Bouffet, E & Bailey, S 2023, 'SIOP PODC–adapted treatment guidelines for craniopharyngioma in low- and middle-income settings', Pediatric Blood and Cancer, vol. 70, no. 11, e28493. https://doi.org/10.1002/pbc.28493

TY - JOUR

T1 - SIOP PODC–adapted treatment guidelines for craniopharyngioma in low- and middle-income settings

AU - Amayiri, Nisreen

AU - Spitaels, Ariane

AU - Zaghloul, Mohamed

AU - Figaji, Anthony

AU - Cavalheiro, Sergio

AU - Muller, Hermann L.

AU - Elhassan, Moawia

AU - Parkes, Jeannette

AU - Mushtaq, Naureen

AU - Beltagy, Mohamed El

AU - Yousef, Yacoub A.

AU - Esiashvili, Natia

AU - Sullivan, Michael

AU - da Costa, Marcos Devanir

AU - Dastoli, Patricia

AU - Mubarak, Fatima

AU - Bartels, Ute

AU - Chamdine, Omar

AU - Davidson, Alan

AU - Musharbash, Awni

AU - Alcasabas, Patricia

AU - Bouffet, Eric

AU - Bailey, Simon

PY - 2023/11

Y1 - 2023/11

N2 - Pediatric craniopharyngioma is a rare tumor with excellent survival but significant long-term morbidities due to the loco-regional tumor growth or secondary to its treatment. Visual impairment, panhypopituitarism, hypothalamic damage, and behavioral changes are among the main challenges. This tumor should be managed under the care of a multidisciplinary team to determine the optimum treatment within the available resources. This is particularly important for low middle-income countries where resources are variable. This report provides risk-stratified management guidelines for children diagnosed with craniopharyngioma in a resource-limited setting.

AB - Pediatric craniopharyngioma is a rare tumor with excellent survival but significant long-term morbidities due to the loco-regional tumor growth or secondary to its treatment. Visual impairment, panhypopituitarism, hypothalamic damage, and behavioral changes are among the main challenges. This tumor should be managed under the care of a multidisciplinary team to determine the optimum treatment within the available resources. This is particularly important for low middle-income countries where resources are variable. This report provides risk-stratified management guidelines for children diagnosed with craniopharyngioma in a resource-limited setting.

KW - LMIC

KW - SIOP PODC

KW - adapted guidelines

KW - craniopharyngioma

UR - http://www.scopus.com/inward/record.url?scp=85089400540&partnerID=8YFLogxK

U2 - 10.1002/pbc.28493

DO - 10.1002/pbc.28493

M3 - Article

AN - SCOPUS:85089400540

SN - 1545-5009

VL - 70

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 11

M1 - e28493

ER -

SIOP PODC–adapted treatment guidelines for craniopharyngioma in low- and middle-income settings

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this